GSK-203168

Study Sponsor: GSK

Study Title

A multicenter, randomized, double-blind (sponsor-unblinded), placebo-controlled study to investigate the safety and tolerability, pharmacokinetics, pharmacodynamics, and efficacy of GSK2982772 in subjects with moderate to severe rheumatoid arthritis

Medicine or Vaccine (generic name)

GSK2982772

Sponsor Identification Number

203168

Trial Registry Identification Number(#'s)

NCT02858492 2016-000912-13

Medical Condition

Arthritis, Rheumatoid

Phase

Phase 2

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=203168

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT02858492

Link to study details on EudraCT (if available)

https://www.clinicaltrialsregister.eu/ctr-search/search?query=/2016-000912-13

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

The raw data are included within the analysis-ready data for this study and are not provided separately

Date Added to this Site

April 2021